Objective:

To investigate the role of metformin in reducing posterior capsule opacification (PCO) after cataract surgery.

Approach:

Key Findings:

• Metformin was detectable in all lens capsule specimens, indicating systemic exposure translates into intraocular tissue levels.
• Capsule concentrations did not differ significantly between low-dose and high-dose groups.
• Metformin significantly attenuated LEC proliferation in vitro compared to controls.

Interpretation:

The findings suggest that metformin may play a protective role against PCO by suppressing LEC proliferation, potentially explaining conflicting epidemiological data regarding diabetes and PCO risk.

Limitations:

• Study involved a small sample size of 20 patients.
• Variability in serum levels due to interindividual differences in metformin pharmacokinetics.

Conclusion:

The study provides evidence that metformin accumulates in the human lens capsule and suppresses LEC proliferation, warranting larger studies to explore its potential as a pharmacological adjunct in PCO prevention.

Sources:

• British Journal of Ophthalmology
Source

Based on findings from:

Metformin’s Potential Role in PCO

Conexiant News Staff. Conexiant, 2026.

https://conexiant.com/ophthalmology/articles/metformins-potential-role-in-pco/

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.